NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









BioCircuit Technologies

BioCircuit Technologies

Private
Atlanta, GeorgiaHealthcare & Life Scienceshttps://www.biocircuit.com/

Last Round

Grant

Nov 20, 2024

Total Funding Raised

$21.06M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

BioCircuit Technologies is a medical device company that develops and commercializes advanced solutions for tissue repair and neuromodulation, including its flagship sutureless nerve repair product, Nerve Tape®.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

nerve repairmedical devicemedtechperipheral nerve surgerynerve regenerationnerve protectorsutureless nerve repairnerve wrapbiomaterialssurgical toolsnerve cuffbioelectronicsreconstructive surgerynitinol microhooks

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BioCircuit Technologies Comparables

Compare BioCircuit Technologies with similar companies based on industry and business-model similarity.

BioCircuit Technologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Neuraptive Therapeutics
89%
Tissium
86%
Swan NeuroTech
84%

BioCircuit Technologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 20, 2024
GrantOct 19, 2023
SeedSep 27, 2022
GrantMay 4, 2021
SeedApr 22, 2021

Key People

Founding team and executive leadership

Michelle Jarrard

CEO

Executive Team

BioCircuit Technologies Investors

Notable investors and investment history

BioCircuit Technologies investors
InvestorRounds
NIH RADxGrant
Georgia Research AllianceSeed
Masters Capital ManagementSeed
Alsora CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors increased 56% MoM.

  • Sep 10, 2025

    Launched the ConformaWrap nerve protector.

BioCircuit Technologies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BioCircuit Technologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BioCircuit Technologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersAtlanta, Georgia
Employee Range45
Year Founded2016
Last FundingNov 20, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.